Weight loss drugs could have cardiovascular benefits, new research shows New research has revealed that semaglutide, the active ingredient in weight loss jabs such as Wegovy and Ozempic, could reduce a persons risk of dangerous heart events such as a heart attack and stroke, regardless of the amount of weight lost
Contact your healthcare provider if you experience persistent fasting glucose above 180 mg/dL, random glucose above 250 mg/dL, or symptoms of hyperglycemia (excessive thirst, frequent urination, blurred vision)
Hand Clin 27(3):263272 Atzei A, Rizzo A, Luchetti R, Fairplay T (2008) Arthroscopic foveal repair of triangular fibrocartilage complex peripheral lesion with distal radioulnar joint instability
December 2025 (Complete) TRIUMPH-4 Phase 3 topline results released